Breast cancer trends and outcomes among young Black Women: A national cancer database analysis.

IF 2.7 3区医学 Q1 SURGERY

American journal of surgery Pub Date : 2025-08-13 DOI:10.1016/j.amjsurg.2025.116577

Danielle M Thompson, Kristine Kuchta, Sandra Simovic, Katharine A Yao

{"title":"Breast cancer trends and outcomes among young Black Women: A national cancer database analysis.","authors":"Danielle M Thompson, Kristine Kuchta, Sandra Simovic, Katharine A Yao","doi":"10.1016/j.amjsurg.2025.116577","DOIUrl":null,"url":null,"abstract":"Introduction: This study examined recent trends and outcomes in breast cancer among Black women under age forty.Methods: Breast cancer incidence data from the National Cancer Database (2010-2022) were analyzed using U.S. Census data population estimates.Results: Among 188,311 women under forty, 16.4 % were Black, compared to 11.3 % in older Black women. From 2010 to 2022, incidence in young Black women rose 5.3 %, compared to 19.9 % in White, 27.7 % in Hispanic, and 18.9 % in Asian/Pacific Islander women. Triple-negative breast cancer was more common in young Black women (16.3 %) vs. young Non-Black women (12.1 %). Black women under forty had 50 % higher odds of death (OR 1.50; 95 % CI: 1.46-1.55, p < .0001) compared to their Non-Black peers after adjusting for age, tumor characteristics, and treatment.Conclusions: Young Black women have more aggressive breast cancers and worse overall survival than Non-Black young women, though incidence has remained stable over the past decade.","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":" ","pages":"116577"},"PeriodicalIF":2.7000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amjsurg.2025.116577","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: This study examined recent trends and outcomes in breast cancer among Black women under age forty.

Methods: Breast cancer incidence data from the National Cancer Database (2010-2022) were analyzed using U.S. Census data population estimates.

Results: Among 188,311 women under forty, 16.4 % were Black, compared to 11.3 % in older Black women. From 2010 to 2022, incidence in young Black women rose 5.3 %, compared to 19.9 % in White, 27.7 % in Hispanic, and 18.9 % in Asian/Pacific Islander women. Triple-negative breast cancer was more common in young Black women (16.3 %) vs. young Non-Black women (12.1 %). Black women under forty had 50 % higher odds of death (OR 1.50; 95 % CI: 1.46-1.55, p < .0001) compared to their Non-Black peers after adjusting for age, tumor characteristics, and treatment.

Conclusions: Young Black women have more aggressive breast cancers and worse overall survival than Non-Black young women, though incidence has remained stable over the past decade.

查看原文本刊更多论文

年轻黑人女性的乳腺癌趋势和结果：国家癌症数据库分析。

引言：本研究调查了40岁以下黑人女性乳腺癌的最新趋势和结果。方法：使用美国人口普查数据对2010-2022年美国国家癌症数据库中的乳腺癌发病率数据进行分析。结果：在188,311名40岁以下的女性中，16.4%是黑人，而在老年黑人女性中，这一比例为11.3%。从2010年到2022年，年轻黑人女性的发病率上升了5.3%，而白人女性为19.9%，西班牙裔女性为27.7%，亚洲/太平洋岛民女性为18.9%。三阴性乳腺癌在年轻黑人女性（16.3%）中比年轻非黑人女性（12.1%）更常见。40岁以下的黑人妇女的死亡率高出50% (OR 1.50; 95% CI: 1.46-1.55, p <。0001)在调整了年龄、肿瘤特征和治疗后，与非黑人同龄人相比。结论：与非黑人年轻女性相比，年轻黑人女性患侵袭性乳腺癌的几率更高，总体生存率更低，尽管在过去十年中发病率保持稳定。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American journal of surgery 医学-外科

CiteScore

5.00

自引率

6.70%

发文量

570

审稿时长

56 days

期刊介绍： The American Journal of Surgery® is a peer-reviewed journal designed for the general surgeon who performs abdominal, cancer, vascular, head and neck, breast, colorectal, and other forms of surgery. AJS is the official journal of 7 major surgical societies* and publishes their official papers as well as independently submitted clinical studies, editorials, reviews, brief reports, correspondence and book reviews.